These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2646988)

  • 1. Daily change of an antiseptic dressing does not prevent infusion phlebitis: a controlled trial.
    Leibovici L
    Am J Infect Control; 1989 Feb; 17(1):23-5. PubMed ID: 2646988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of peripheral vein phlebitis associated with chlorhexidine-coated catheters: a randomized, double-blind trial.
    Sherertz RJ; Stephens JL; Marosok RD; Carruth WA; Rich HA; Hampton KD; Motsinger SM; Harris LC; Scuderi PE; Pappas JG; Felton SC; Solomon DD
    Infect Control Hosp Epidemiol; 1997 Apr; 18(4):230-6. PubMed ID: 9131364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of the transparent sterile dressing vs standard to fix the peripheral venous catheter (PVC) on the incidence of phlebitis. A randomized controlled trial].
    Forni C; D'Alessandro F; Gambino O; Amodeo A; Pignotti E; Zanotti E; Tremosini M; Trofa C; Sabattini T; Matino F; Genco R; Schiavone M; Bombino C; Mini S; Rocchegiani L; Notarnicola T; Capezzali D; Boschi R; Loro L
    Assist Inferm Ric; 2012; 31(2):63-9. PubMed ID: 22825293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing.
    Maki DG; Ringer M
    JAMA; 1987 Nov; 258(17):2396-403. PubMed ID: 3118061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protect peripheral intravenous catheters: a study protocol for a randomised controlled trial of a novel antimicrobial dressing for peripheral intravenous catheters (ProP trial).
    Rickard CM; Drugeon B; Ullman A; Marsh NM; Corley A; Ball D; O'Brien C; Kleidon TM; Guenezan J; Couvreur R; McCarthy KL; Seguin S; Batiot G; Byrnes J; Schults J; Zahir SF; Mimoz O
    BMJ Open; 2024 Jul; 14(7):e084313. PubMed ID: 39013653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dressing type and change interval on intravenous therapy complication rates.
    Gantz NM; Presswood GM; Goldberg R; Doern G
    Diagn Microbiol Infect Dis; 1984 Sep; 2(4):325-32. PubMed ID: 6488748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of alcohol 70% versus alcoholic iodine 2% in skin disinfection before insertion of peripheral infusion catheters.
    de Vries JH; van Dorp WT; van Barneveld PW
    J Hosp Infect; 1997 Aug; 36(4):317-20. PubMed ID: 9261762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descriptive study.
    Uslusoy E; Mete S
    J Am Acad Nurse Pract; 2008 Apr; 20(4):172-80. PubMed ID: 18387013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial colonization and phlebitis-associated risk with transparent polyurethane film for peripheral intravenous site dressings.
    Hoffmann KK; Western SA; Kaiser DL; Wenzel RP; Groschel DH
    Am J Infect Control; 1988 Jun; 16(3):101-6. PubMed ID: 3408013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral intravenous therapy-related phlebitis rates in an adult population.
    White SA
    J Intraven Nurs; 2001; 24(1):19-24. PubMed ID: 11836840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Securing All intraVenous devices Effectively in hospitalised patients--the SAVE trial: study protocol for a multicentre randomised controlled trial.
    Rickard CM; Marsh N; Webster J; Playford EG; McGrail MR; Larsen E; Keogh S; McMillan D; Whitty JA; Choudhury MA; Dunster KR; Reynolds H; Marshall A; Crilly J; Young J; Thom O; Gowardman J; Corley A; Fraser JF
    BMJ Open; 2015 Sep; 5(9):e008689. PubMed ID: 26399574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).
    Günther SC; Schwebel C; Hamidfar-Roy R; Bonadona A; Lugosi M; Ara-Somohano C; Minet C; Potton L; Cartier JC; Vésin A; Chautemps M; Styfalova L; Ruckly S; Timsit JF
    Intensive Care Med; 2016 Nov; 42(11):1753-1765. PubMed ID: 27734108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
    Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
    Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of transdermal glyceryl trinitrate on the survival of peripheral intravenous infusions: a double-blind prospective clinical study.
    Khawaja HT; Campbell MJ; Weaver PC
    Br J Surg; 1988 Dec; 75(12):1212-5. PubMed ID: 3148355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation.
    Cornely OA; Bethe U; Pauls R; Waldschmidt D
    Infect Control Hosp Epidemiol; 2002 May; 23(5):249-53. PubMed ID: 12026149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized Controlled Study to Evaluate the Effectiveness of 2 Treatment Methods in Reducing Incidence of Short Peripheral Catheter-Related Phlebitis.
    Gunasegaran N; See MTA; Leong ST; Yuan LX; Ang SY
    J Infus Nurs; 2018; 41(2):131-137. PubMed ID: 29489709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peripheral venous catheters: incidence of phlebitis and its determining factors].
    Regueiro Pose MA; Souto Rodríguez B; Iglesias Maroño M; Outón Fernández I; Cambeiro Nuñez J; Pértega Díaz S; Pita Fernández S
    Rev Enferm; 2005 Oct; 28(10):21-8. PubMed ID: 16304830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral Venous Catheter-Related Adverse Events: Evaluation from a Multicentre Epidemiological Study in France (the CATHEVAL Project).
    Miliani K; Taravella R; Thillard D; Chauvin V; Martin E; Edouard S; Astagneau P;
    PLoS One; 2017; 12(1):e0168637. PubMed ID: 28045921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the influence of risk factors on rates and dynamics of peripheral vein phlebitis: an observational cohort study.
    Mestre Roca G; Berbel Bertolo C; Tortajada Lopez P; Gallemi Samaranch G; Aguilar Ramirez MC; Caylà Buqueras J; Rodríguez-Baño J; Martinez JA
    Med Clin (Barc); 2012 Jul; 139(5):185-91. PubMed ID: 22538061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters.
    Maki DG; Ringer M; Alvarado CJ
    Lancet; 1991 Aug; 338(8763):339-43. PubMed ID: 1677698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.